State-level medical and absenteeism cost of asthma in the United States
State-level medical and absenteeism cost of asthma in the United States
复制标题
DOI：
10.1080/02770903.2016.1218013
复制
发表时间：
2017-01-01
影响因子：
1.9
通讯作者：
Orenstein, Diane
中科院分区：
文献类型：
--
作者：
Nurmagambetov, Tursynbek;Khavjou, Olga;Orenstein, Diane
目的：对于药物治疗的哮喘，我们使用最新的可用数据估计了美国50个州和哥伦比亚特区（DC）的总人口和儿童在2015年至2020年的患病率、医疗和缺勤成本以及预计医疗成本。研究方法：我们使用了多个数据来源，包括医疗支出调查，美国人口普查局，凯撒家庭基金会，医疗统计信息系统和当前人口调查。我们使用两部分回归模型来估计哮喘的年度医疗费用，并使用负二项模型来估计每年因哮喘而缺课和工作的天数。结果：哮喘的人均医疗费用从1,860美元（密西西比）到2,514美元（密歇根）不等。哮喘的总医疗费用从6070万美元（怀俄明州）到34亿美元（加州）不等。医疗补助费用从410万美元（怀俄明州）到5.668亿美元（加州）不等，医疗保险从590万美元（华盛顿特区）到4.466亿美元（加州）不等，私人保险公司支付的费用从2720万美元（华盛顿特区）到14亿美元（加州）不等。每年因哮喘而损失的学校和工作总天数从2.24万（怀俄明州）到150万（加利福尼亚州）不等，缺勤成本从440万美元（怀俄明州）到3.45亿美元（加州）不等。预计2015年至2020年的医疗费用增长幅度从9%（DC）到34%（亚利桑那州）不等。结论：哮喘的医疗和缺勤费用对各州来说是一个巨大的经济负担，预计这些费用将上升。我们的研究结果强调了加强州一级预防和控制哮喘发作的战略的紧迫性。
Objective: For medically treated asthma, we estimated prevalence, medical and absenteeism costs, and projected medical costs from 2015 to 2020 for the entire population and separately for children in the 50 US states and District of Columbia (DC) using the most recently available data. Methods: We used multiple data sources, including the Medical Expenditure Panel Survey, U.S. Census Bureau, Kaiser Family Foundation, Medical Statistical Information System, and Current Population Survey. We used a two-part regression model to estimate annual medical costs of asthma and a negative binomial model to estimate annual school and work days missed due to asthma. Results: Per capita medical costs of asthma ranged from $1,860 (Mississippi) to $2,514 (Michigan). Total medical costs of asthma ranged from $60.7 million (Wyoming) to $3.4 billion (California). Medicaid costs ranged from $4.1 million (Wyoming) to $566.8 million (California), Medicare from $5.9 million (DC) to $446.6 million (California), and costs paid by private insurers ranged from $27.2 million (DC) to $1.4 billion (California). Total annual school and work days lost due to asthma ranged from 22.4 thousand (Wyoming) to 1.5 million days (California) and absenteeism costs ranged from $4.4 million (Wyoming) to $345 million (California). Projected increase in medical costs from 2015 to 2020 ranged from 9% (DC) to 34% (Arizona). Conclusion: Medical and absenteeism costs of asthma represent a significant economic burden for states and these costs are expected to rise. Our study results emphasize the urgency for strategies to strengthen state level efforts to prevent and control asthma attacks.